Azenta, Inc. (AZTA)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Azenta, Inc. keeps $2 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 20
in 26 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Azenta topped consensus on both the top and bottom line in the third fiscal quarter of 2026, reported August 4, 2026, with adjusted EPS of $0.16 topping the $0.11 estimate (+41%) even as it fell -15.8% from $0.19 a year ago. Revenue rose 12.0% to roughly $161.2 million (up from about $143.9 million a year ago) and also topped expectations, coming in at $161.2 million versus a $149.3 million estimate (+8%). Profitability was mixed: gross profit was about $72.4 million, translating to a gross margin of roughly 45%, while operating results were negative with operating income of roughly -$4.2 million and an operating margin of about -3%. The company generated about $2.8 million of operating cash flow during the quarter and repurchased roughly $50.0 million of stock. For the next period, consensus calls for EPS of $0.16 on revenue of $160.3 million.
Next report — what to expect
Azenta, Inc. (AZTA) is set to report earnings on November 20, 2026. Wall Street is looking for consensus EPS of $0.119 on revenue of $160.2 million. For trailing context, revenue grew +12.0% year over year last quarter. AZTA has beaten EPS in 5 of 8 most recent quarters.
About Azenta, Inc.
Azenta, Inc. provides tools and services for handling life science samples, operating in healthcare through laboratory instruments, supplies, and related services. On NASDAQ under AZTA, the company specializes in the discovery, handling, and preservation of those samples and recorded $593.8 million of revenue in FY2025.
Today's Snapshot
The day ended with AZTA 1.4% higher at 36.50, outperforming a weaker sector. Shares changed hands at about half of its usual level.
Trading Volume
Below 10d avg (876.7K)
458.1K
vs S&P 500 Today
Outperforming Market
+1.88%
Updated: October 23, 2026 at 20:10 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$30.75 - $36.24Buy
- RSI (14)53.27Neutral
- Stochastic %K (14, 3, 3)25.36Neutral
- MACD Level (12, 26)0.56Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.